Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: Implications with valve dysfunction

Annals of Thoracic Surgery

Volumn 78, Issue 2, 2004, Pages 557-563

  Pompilio, Giulio ^a   Polvani, Gianluca ^a   Piccolo, Giuseppe ^b   Guarino, Anna ^a   Nocco, Angela ^b   Innocente, Annalisa ^b   Porqueddu, Massimo ^a   Dainese, Luca ^a   Veglia, Fabrizio ^a   Sala, Andrea ^c   Biglioli, Paolo ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

Author keywords

35

Indexed keywords

ADULT; ALLOGRAFT; ANTIBODY RESPONSE; AORTA VALVE; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CORRELATION ANALYSIS; CRYOPRESERVATION; DONOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART VALVE REPLACEMENT; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LYMPHOCYTE; MALE; MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; REOPERATION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AORTIC VALVE; BIOPROSTHESIS; CRYOPRESERVATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART VALVE PROSTHESIS; HLA ANTIGENS; HUMANS; IMMUNIZATION; ISOANTIBODIES; MALE; MIDDLE AGED; ORGAN PRESERVATION; PROSPECTIVE STUDIES; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 3242789284     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.02.037     Document Type: Article

References (20)

1. Yacoub M., Rasmi N.R.H., Sundt T.M., et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg. 110:1995;186-189
2. Grunkemeier G.L., Bodnar E. Comparison of structural valve failure among different "models" of homograft valves. J Heart Valve Dis. 3:1994;556-560
3. Lund O., Chandrasekaran V., Grocott-Mason R., et al. Primary aortic valve replacement with allografts over twenty-five years valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg. 117:1999;77-91
4. Palka P., Harrocks S., Lange A., Burstow D.J., O'Brien M.F. Primary aortic valve replacement with cryopreserved aortic allograft. An echocardiographic follow-up study of 570 patients. Circulation. 105:2002;61-66
5. O'Brien M.F., McGiffin D.C., Stafford E.G., et al. Allograft aortic valve replacement long-term comparative clinical analysis of viable cryopreserved and antibiotic stored 4°C stored valves. J Card Surg. 6:1991;534-543
6. Yankah A.C., Wottge H.U., Müller-Ruchholtz W. Antigenicity and fate of cellular components of heart valve allografts. Yankah A.C., Hertzer R., Miller D.C., Ross D.N., Somerville J., Yacoub M.H. Cardiac valve allografts 1962-1987,1st ed. 1987;77-87 Springer-Verlag, New York
7. Yacoub L.H., Suitters A., Khaghani A., Rose M.L. Localization of major histocompatibility complex antigens in aortic homograft. Bodnar E., Yacoub M.H. Biologic and bioprosthetic valves. Proceedings of the Third International Symposium. 1986;63-72 Yorke Medical Books, New York
8. Hoekstra F.M.E., Witvliet M., Knoop C.Y., et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg. 66:1998;2022-2026
9. Hogan P., Duplock L., Green M., et al. Human aortic valve allografts elicit a donor-specific immune response. J Thorac Cardiovasc Surg. 112:1996;1260-1267
10. Smith J.D., Ogino H., Hunt D., Laylor R.M., Rose M.L., Yacoub M.H. Humoral immune response to human aortic valve homografts. Ann Thorac Surg. 60:(Suppl):1995;S127-130
11. Smith J.D., Hornick P.I., Rasmi N., Rose M.L., Yacoub M.H. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. Ann Thorac Surg. 66:(Suppl):1998;S212-213
12. Bechtel J.F.M., Bartels C., Schmidtke C., et al. Does histocompatibility affect homograft valve function after the Ross procedure? Circulation. 104:(Suppl 1):2001;I-25-28
13. Dignan R., O'Brien M., Hogan P., et al. Influence of HLA matching, and associated factors on aortic valve homograft function. J Heart Valve Dis. 9:2000;504-511
14. O'Brien M., McGiffin D.C., Stafford E.G. Allograft aortic valve implantation techniques for all types of aortic valve and root pathology. Ann Thorac Surg. 48:1989;600-609
15. European Foundation for Immunogenetics. Standards for histocompatibility testing, 4th version, June 19, 2000
16. Gall K., Smith S., Willmette C., et al. Allograft heart valve viability a quantitative assessment of the effects of valve processing on fibroblast viability and valve processing variables. Ann Thorac Surg. 65:1998;1032-1038
17. Valente M., Faggian G., Billingham M.E., et al. The aortic valve after heart transplantation. Ann Thorac Surg. 60:(Suppl):1995;S135-140
18. Green M.K., Walsh M.D., Dare A., et al. Histological and immunohistochemical responses after valve allografts in the rat. Ann Thorac Surg. 66:(Suppl):1998;S216-220
19. Bechtel J.F.M., Bartels C., Schmidtke C., et al. Anti-HLA class I antibodies, and pulmonary homograft function after the Ross procedure. Ann Thorac Surg. 71:2001;2003-2007
20. Stabb M.E., Nishimura R.A., Dearani J.A., et al. Aortic valve homograft in adults a clinical perspective. Mayo Clin Proc. 73:1998;231-238